Literature DB >> 10403541

G6PD activity and gene expression in leukemic cells from G6PD-deficient subjects.

B Batetta1, D Pulisci, R R Bonatesta, F Sanna, S Piras, M F Mulas, O Spano, M Putzolu, G Broccia, S Dessì.   

Abstract

In the present study we examined gene expression and glucose-6-phosphate dehydrogenase (G6PD) activity in leukemic cells isolated from G6PD normal and deficient subjects. The results have shown that G6PD activity strongly increases in G6PD normal leukemic cells as well as in G6PD deficient leukemic cells when compared to peripheral blood mononuclear cells (PBMC). Higher levels of G6PD gene expression were observed in leukemic cells from G6PD deficient patients compared to G6PD normal. A similar pattern of gene expression was also observed for 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase. These results support the hypothesis that G6PD deficient cell, in order to sustain their growth, must respond to the low activity of their mutant enzyme with an increase in quantity through an induction of gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403541     DOI: 10.1016/s0304-3835(99)00052-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Expression signatures of early-stage and advanced medaka melanomas.

Authors:  Barbara Klotz; Susanne Kneitz; Martina Regensburger; Lena Hahn; Michael Dannemann; Janet Kelso; Birgit Nickel; Yuan Lu; William Boswell; John Postlethwait; Wesley Warren; Manfred Kunz; Ronald B Walter; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-11-21       Impact factor: 3.228

2.  Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells.

Authors:  B Batetta; R R Bonatesta; F Sanna; M Putzolu; M F Mulas; M Collu; S Dessì
Journal:  Cell Prolif       Date:  2002-06       Impact factor: 6.831

3.  Elevated glucose-6-phosphate dehydrogenase expression in the cervical cancer cases is associated with the cancerigenic event of high-risk human papillomaviruses.

Authors:  Tao Hu; Ya-Shan Li; Bo Chen; Ye-Fei Chang; Guang-Cai Liu; Ying Hong; Hong-Lan Chen; Yan-Bin Xiyang
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-23

4.  How We Manage Invasive Fungal Disease in Acute Myeloid Leukemia Patients with Glucose 6 Dehydrogenase Deficiency.

Authors:  Marco Sanna; Giovanni Caocci; Giorgio La Nasa
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-14       Impact factor: 2.576

5.  SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation.

Authors:  Shuang-Nian Xu; Tian-Shi Wang; Xi Li; Yi-Ping Wang
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

6.  Data mining and pathway analysis of glucose-6-phosphate dehydrogenase with natural language processing.

Authors:  Long Chen; Chunhua Zhang; Yanling Wang; Yuqian Li; Qiaoqiao Han; Huixin Yang; Yuechun Zhu
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

7.  miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.

Authors:  Tao Hu; Ye-Fei Chang; Zhangang Xiao; Rui Mao; Jun Tong; Bo Chen; Guang-Cai Liu; Ying Hong; Hong-Lan Chen; Shu-Yi Kong; Yan-Mei Huang; Yan-Bin Xiyang; Hua Jin
Journal:  Oncotarget       Date:  2016-12-27

8.  Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.

Authors:  Tao Hu; Chunhua Zhang; Qiongling Tang; Yanan Su; Bo Li; Long Chen; Zheng Zhang; Tianchi Cai; Yuechun Zhu
Journal:  BMC Cancer       Date:  2013-05-22       Impact factor: 4.430

9.  G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients.

Authors:  Maria Pina Dore; Giuseppina Marras; Chiara Rocchi; Sara Soro; Giovanni Mario Pes
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  Proteomic Investigation to Identify Anticancer Targets of Nemopilema nomurai Jellyfish Venom in Human Hepatocarcinoma HepG2 Cells.

Authors:  Indu Choudhary; Hyunkyoung Lee; Min Jung Pyo; Yunwi Heo; Jinho Chae; Seung Shic Yum; Changkeun Kang; Euikyung Kim
Journal:  Toxins (Basel)       Date:  2018-05-10       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.